AdvisorShares Trust → PSYENCE BIOMEDICAL LTD. PBMWW

Stake: — Shares: — Class: Common shares, without par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.00

17,933 shares short · +11.4% vs prior

Other 13D/G Filings on PSYENCE BIOMEDICAL LTD.

Filed	Form	Filer	Stake	Shares
2026-10-15	SCHEDULE 13D/A	Psyence Labs Ltd	—	2,643,659	view →
2026-06-10	SCHEDULE 13G/A	Weiner Jeffrey David	—	—	view →
2026-06-03	SCHEDULE 13D	Psyence Labs Ltd	30.05%	1,146,159	view →
2026-01-13	SCHEDULE	Kaos Capital Ltd	4.91%	313,876	view →

Other Filings by AdvisorShares Trust

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13G	Neuphoria Therapeutics Inc.	—	—	view →
2026-07-08	SCHEDULE 13G	Quantum Biopharma Ltd. QNTM	—	—	view →
2026-07-08	SCHEDULE 13G	Trulieve Cannabis Corp. TCNNF	—	—	view →
2026-07-08	SCHEDULE 13G	Silo Pharma, Inc. SILO	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →